Thrombolytic therapy at systemic lupus onset with secondary antiphospholipid syndrome

@inproceedings{Loharia2015ThrombolyticTA,
  title={Thrombolytic therapy at systemic lupus onset with secondary antiphospholipid syndrome},
  author={Juned J. Loharia and Junaid Alam and Hassan A. Abdelhadi and Tamer F. Marei},
  booktitle={Neurosciences},
  year={2015}
}
Strokes are a major cause of disability in systemic lupus erythematosus (SLE). Classical neurological manifestations are rare at onset. The use of thrombolytic therapy improves clinical outcome in eligible stroke patients who present early. Modern imaging modalities augment decision making. This 37-year-old woman presented with an acute stroke with National Institute of Health stroke scale 10. The CT showed a hyperdense middle cerebral artery (MCA) dot sign. The magnetic resonance angiography… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

and stroke severity in systemic lupus erythematosus

  • J Nojima, H Kuratsune, E Suehisa, T Kitani, Y Iwatani, Y Kanakura
  • 2007

Similar Papers

Loading similar papers…